Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
- Published In:
- Human reproduction update, 20(5), 688-701 (2014)
- Database ID:
- RPEP-02339
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02339APA
Broer, Simone L; Broekmans, Frank J M; Laven, Joop S E; Fauser, Bart C J M. (2014). Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.. Human reproduction update, 20(5), 688-701. https://doi.org/10.1093/humupd/dmu020
MLA
Broer, Simone L, et al. "Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.." Human reproduction update, 2014. https://doi.org/10.1093/humupd/dmu020
RethinkPeptides
RethinkPeptides Research Database. "Anti-Müllerian hormone: ovarian reserve testing and its pote..." RPEP-02339. Retrieved from https://rethinkpeptides.com/research/broer-2014-antimllerian-hormone-ovarian-reserve
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.